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Article Synopsis  
Pharmacy is evolving from a product-oriented to a patient-oriented profession. This role modification is extremely healthy for the 
patient, the pharmacist, and other members of the health-care team. However, the evolution will present pharmacists with a number 
of new challenges. Now, more than in the past, pharmacists must make the acquisition of contemporary practice knowledge and skills 
a high priority, to render the level of service embodied in the concept of pharmaceutical care. Pharmacy educators’ organizations and 
regulatory bodies must all work together to support pharmacists as they assume expanded health-care roles. Pharmacy and the health-
care industry must work to ensure that the pharmacist is compensated justly for all services. But before this can happen it will be 
necessary for pharmacy to demonstrate value-added to the cost of the prescription. Marketing of the purpose of pharmacy in the 
health-care morass and of the services provided by the pharmacist is needed to generate an appropriate perceived value among 
purchasers and users of health-care services. Pharmacists should view themselves as dispensers of therapy and drug effect 
interpretations as well as of drugs themselves. Service components of pharmacy should be identified clearly to third party payers and 
be visible to consumers, so that they know what is available at what cost and how it may be accessed. In the future, pharmacy services 
must be evaluated on patient outcome (i.e., pharmaceutical care) rather than the number of prescriptions dispensed, and pharmacy 
must evolve toward interpretation and patient consultation, related to the use of medication technologies. 
 
 
 
ABSTRACT 
Ambulatory care pharmacy practice is defined as the provision 
of integrated, accessible healthcare services by pharmacists 
who are accountable for addressing medication needs, 
developing sustained partnerships with patients, and practicing 
in the context of family and community. This is accomplished 
through direct patient care and medication management for 
ambulatory patients, long-term relationships, coordination of 
care, patient advocacy, wellness and health promotion, triage 
and referral, and patient education and self-management. The 
ambulatory care pharmacists may work in both an institutional 
and community-based clinic involved in direct care of a diverse 
patient population.  
 
A variety of specialty clinics are available for allergy and 
immunology, pulmonology, endocrinology, cardiology, 
nephrology, neurology, behavioral health, and infectious 
disease. Such services for this population may exist as a primary 
care clinic or an independent specialty clinic, typically in a 
PCMH, which is instrumental in coordinating care between 
various providers. Once a practice site is identified, it is 
important to establish a strong, trusting, and mutually 
beneficial relationship with the various decision-makers (e.g., 
administrators, providers) involved with the clinic. If pharmacy 
services are currently in existence, the pharmacy director may 
be able to identify and initially contact the appropriate person. 
If another pharmacist is providing clinical services, this person 
would be a resource to help determine areas for expansion of 
patient care and to whom to direct the proposed business plan.  
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Additional individuals to consider as an initial point of contact 
include the clinic manager, clinic medical director, or 
administrative assistant to either of these persons. If the clinic 
setting is affiliated with a medical school, it may be necessary 
to contact the Department of Family Medicine head. 
 
Purpose of the study: Discussion and projection of pharmacists’ 
roles and responsibilities in ambulatory care settings. 
Methodology: The research is conducted through secondary 
data search from several sources from books, technical 
newsletters, newspapers, journals, and many other sources. 
The present study was started from the beginning of 2018. 
PubMed, ALTAVISTA, Embase, Scopus, Web of Science, and the 
Cochrane Central Register of was thoroughly searched. The 
keywords were used to search for different publishers’ journals 
like Elsevier, Springer, Willey Online Library, Wolters Kluwer 
were extensively followed. 
Findings: Ambulatory Care Pharmacy addresses the provision 
of integrated, accessible healthcare services of ambulatory 
patients transitioning from the hospital to home or another 
care facility. Given the focus on ambulatory care as an option 
for health system renewal, it is important to evaluate the 
provision of home care services to ensure that care is optimized 
and meets patient needs. 
Limitation of the study: There are too many information 
available regarding ambulatory pharmacists’ roles and 
responsibilities, superiorities in healthcare arena among others 
in healthcare profession. Information only available from 
reputed journals are added here.  
Practical Implication: Students, researchers and professionals 
of different background and disciplines pharmacists, doctors, 
nurses and health regulatory authorities have to acquire much 
from this article. 
 
 
Commentary PHARMACY PRACTICE 
 
http://z.umn.edu/INNOVATIONS                        2019, Vol. 10, No. 1, Article 4                       INNOVATIONS in pharmacy 
                                                                             DOI: https://doi.org/10.24926/iip.v10i1.1622 
2 
 
Keywords: Community pharmacist; Provider; Medication; 
Outpatient; Care 
 
Abbreviations: Patient-Centered Medical Home (PCMH); 
Communication Accommodation Theory (CAT); Medication 
Therapy Management (MTM); Transitions Of Care (TOC); Home 
Medicines Reviews (HMR); Medication Management Review 
(MMR); Pharmaceutical Care (PC); National Association of 
Pharmacy Regulatory Authorities (NAPRA); Interprofessional 
Collaboration (IPC); Drug-related problems (DRPs); Joint 
Commission of Pharmacy Practitioners (JCPP); Medication 
Reconciliation (MR) 
 
INTRODUCTION 
Ambulatory refers to patients not occupying beds in hospitals 
or other inpatient settings. Ambulatory patients are 
noninstitutionalized patients who have the responsibility for 
obtaining their medication, storing it, and taking it. They may or 
may not be outpatients, depending upon where they receive 
their treatment. They may even be in a wheelchair and, strictly 
speaking, not ambulatory, but if they are not institutionalized, 
they will have the same basic responsibility for their medication 
as walking patients. Various designations are used to categorize 
patients: institutionalized, noninstitutionalized, inpatient, 
outpatient, bedridden, and ambulatory. Ambulatory patients 
may be inpatients of an institution, such as a hospital or 
extended-care facility, if they are not confined to bed. However, 
the term ambulatory patient has become more restrictive in its 
modern usage simply to mean a noninstitutionalized patient. 
Whether patients consult a physician who may prescribe 
medication or whether they decide to treat themselves, the 
community pharmacist more than likely will come into contact 
with them. It is important, therefore, for the pharmacist to have 
an understanding of these patients so that as a pharmacist and 
member of the health-care team, the best possible health care 
for ambulatory patients may be provided through proper use of 
knowledge and judgment.  
 
Scope of Ambulatory Care Practice 
Healthcare reform has created a demand for change in the 
delivery of healthcare services. Encouraging the introduction of 
the medication expert in providing patient-centered care is an 
important element in the advancement of delivering quality 
clinical services. The ambulatory setting is where most 
individuals in the US receive health care [1]. Consequently, 
ambulatory care is a growing field of pharmacy practice. 
Employment of registered pharmacists is projected to rise 
dramatically in physician offices and medical center outpatient 
clinics within next 10 years. The literature also supports the 
positive effects of pharmacy practice in ambulatory care 
settings, such as decreased benzodiazepine use, improved 
anxiety scores, improved cardiac outcomes, and improved 
compliance [2]. Healthcare payment reform will have far-
reaching effects on health-system behavior, including a shift of 
resources from inpatient care to ambulatory care. Health 
systems will give renewed attention—well beyond lip service—
to classical public health initiatives (i.e., disease prevention and 
health promotion). They have higher expectations for 
leadership by pharmacists on a broad array of medication-use 
issues that affect institutional success. Given the focus on 
ambulatory care as an option for health system renewal, it is 
important to evaluate the provision of home care services to 
ensure that care is optimized and meets patient needs. A nearly 
85% affirmative response obtained that nearly all health 
systems will have strong financial incentives to keep their 
patients healthy and not in need of high-cost healthcare 
services, particularly inpatient care, reinforces the importance 
of keeping “at-risk” populations healthy. A major implication of 
this prediction is that health-system pharmacy must embrace 
ambulatory care [3]. Pharmacy Forecast 2016–2020, published 
by the American Society of Health-System Pharmacists 
Research and Education Foundation, predicts that health care 
payment reform will result in a significant shift of health-system 
resources from inpatient to ambulatory care. Health care 
delivery and financing will move assertively to expand 
pharmacist services in ambulatory-care clinics [4,5]. The 
forecast is the fourth annual report the foundation has 
produced for hospital and health-system pharmacists. Other 
highlighted topics include: 
 
 The need to optimize the deployment of pharmacy 
talent. 
 An emerging oversupply in some regions of 
pharmacists for entry-level positions. 
 New tools to measure and improve pharmacist and 
departmental performance. 
 Continuing attention to “meaningful-use” 
requirements for information technology. 
 Implications of the patient empowerment movement 
for pharmacies [6]. 
 
Optimizing pharmacy workforces over the next five years will 
involve placing greater emphasis on ambulatory care. Three-
fourths of the forecast panelists believe that at least a quarter 
of health systems will require patient-care pharmacists to be 
responsible for both inpatients and outpatients. Also, at least a 
quarter of health systems are expected to shift 10% or more of 
their inpatient pharmacy positions to ambulatory-care 
positions. This shift towards ambulatory care is expected to 
result in a vacancy rate of at least 10% for ambulatory-care 
pharmacy leadership positions [7]. 
 
Pharmacists in Ambulatory Care 
All people who take medications are at risk of actual or 
potential drug therapy problems. These problems are a 
significant source of morbidity and mortality when left 
undetected and unresolved and drive huge costs across the 
health system. As drug therapy experts, pharmacists provide 
drug therapy management services built around a partnership 
between the pharmacist, the patient (or his or her caregiver), 
physicians and other members of a patient’s health care team. 
As ambulatory care pharmacy practice grows, there has been 
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an ongoing effort to identify the desired role of the staff 
pharmacists in outpatient care and to provide linkages to 
preferred outcomes. In at least 25% of health systems, patient 
care pharmacists will have umbrella responsibilities, 
encompassing both inpatients and outpatients, for pursuing the 
best outcomes from drug therapy [4]. Their vision is to be a 
reliably standard setting in its provision of direct patient care 
and to continuously develop methods that improve this 
practice.  They facilitate safe, effective, efficient and 
economical use of medications with the aim of optimizing 
patient care by qualified and trained staff. Pharmacists play an 
essential role in the safe, quality and effective use of 
medications in improving patient’s physical and mental 
wellness [8].  They are instrumental in managing medication-
related issues to complement the holistic care for patients 
throughout   the   organization.   Pharmacists   provide   
education   to patients and caregivers on the safe and 
appropriate use of medications, counsel on medication 
compliance, monitor and manage medication side effects, as 
well as screen for dangerous drug interactions [9].  In addition, 
they specialize in recommending optimal medication therapy 
for concurrent medical problems, with the aim of enhancing 
treatment outcomes and facilitating the continuity of care as 
patients integrate back into the community [10-14].   
 
Expertise in Therapy Management 
The goal of pharmacy service is to identify and resolve actual or 
potential drug therapy problems for patients and to promote 
the safe and effective use of medications and enable patients 
to achieve positive, targeted therapy outcomes. The 
medication management framework includes the following: 
 
A. Assessment: The pharmacist assesses each patient 
through observation, dialogue and consideration of clinical 
indicators. Medication counselling opportunities are key 
times for pharmacists and patients to discuss medications 
and patients’ concerns about their therapy. 
Communication Accommodation Theory (CAT) describes 
behavioral, motivational and emotional processes 
underlying communication exchanges. Five CAT strategies 
(approximation, interpretability, discourse management, 
emotional expression and interpersonal control) permit 
identification of effective communication. In most 
European countries, feedback is embedded in education, 
training and daily professional activities. It is a valuable tool 
for indicating whether things are going in the right 
direction or whether redirection is required. Treatment 
alternatives are assessed for appropriateness, 
effectiveness and safety (including interactions), to 
prevent and resolve medication-related problems [15-17]. 
B. Care plans: The pharmacist creates a plan in consultation 
with the patient and, when necessary, other members of 
the health care team. The care plan includes goals and 
actions to achieve the patient’s personal health goals 
through optimal drug therapy. Patient participation means 
involvement of the patient in decision making or 
expressing opinions about different treatment methods, 
which includes sharing information, feelings and signs and 
accepting health team instructions [18]. Actions include 
patient and/or caregiver education about chronic disease, 
writing a prescription to continue care, initiating new 
treatment and disease prevention such as immunization 
and lifestyle modification programs. There is a huge 
opportunity for pharmacists to have a significant impact on 
reducing healthcare costs, as they have the expertise to 
detect, resolve, and prevent medication errors and 
medication-related problems [19]. Care plans also include 
medication support systems such as compliance packaging 
and medication reminders. 
C. Monitoring compliance and evaluating effectiveness: 
Adherence to therapies is a primary determinant of 
treatment success. Failure to adherence is a serious 
problem which not only affects the patient but also the 
health care system. The pharmacist monitors the patient’s 
compliance with and response to drug therapy through 
regular follow-ups [20,21]. Tertiary hospitals manage 
patients with complex care needs. Hospital pharmacists 
frequently dispense medicines when there is limited global 
experience with use, but where local prescribers feel their 
benefit outweighs the risk. These allow for progress 
evaluation and support and early detection of adverse 
effects, drug misuse or abuse [22].  
 
Committed Relationship with Patients 
Many patients interact with the health system at multiple 
points. Medication therapy may be started, altered or adjusted 
at any point along this continuum of care by multiple providers. 
But pharmacists are the health professionals with the best 
potential to effectively coordinate medication across the 
continuum. As important members of the health care team, 
pharmacists work collaboratively with patients’ other health 
care providers in all types of patient care settings ranging from 
community pharmacies to hospitals and long-term care 
facilities [23]. In particular, community-based pharmacists are 
accessible and uniquely positioned to support a continuum of 
primary care, the challenges of living with chronic disease, 
assisting people to remain in their homes as they age and 
assisting people living with mental illness or chronic diseases 
[24]. The first step in the provision of pharmaceutical care is the 
establishment of a committed relationship with the patient. To 
that end, pharmacists must seek and be granted authority by 
their patients to intervene on their behalf. Pharmacists also 
may need to secure permission from other health-care 
providers and patient caregivers (e.g., in cases in which the 
patient is a child or unable to visit the pharmacy in person) to 
provide pharmaceutical-care services. The key to doing so in all 
instances is effective communication. Building a committed 
relationship cannot occur at a distance. The pharmacist-patient 
relationship has changed over the past 30 years from one in 
which pharmacists focused solely on filling prescriptions 
without questioning a physician’s order to one in which 
pharmacists recommend drug therapy to prescribers and offer 
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personalized advice to patients on how to maximize the 
benefits of their medication [25]. In addition, by its very nature, 
pharmaceutical care is an iterative and ongoing process, as long 
as the patient has unresolved medication-related problems. 
Therefore, once a rapport has been established, the pharmacist 
must interact regularly with the patient to strengthen the 
relationship and to collect additional data necessary to ensure 
that the patient’s pharmaceutical-care needs continue to be 
met [26]. 
 
Provision of Pharmacy Services 
In the initial organizational plan or proposal, it is important to 
detail the individual who will be providing services, the services 
to be provided, the entity (e.g., patient, caregiver, health care 
team) to whom services will be provided, the time required for 
the services, the expected outcomes, and a proposed workflow. 
Ultimately, the goal would be to implement the Pharmacists' 
Patient Care Process as defined by the Joint Commission of 
Pharmacy Practitioners (JCPP). In such a process, the 
pharmacist is integrated into the delivery of care for the patient 
in an interprofessional setting [27]. Services to consider 
implementing include medication reconciliation, MTM, 
preventative services, and patient-specific medication 
education and behavioral counseling. However, outpatient 
pharmacy basic services and functions may include: 
 
A. Medication Dispensing 
The fundamental concept of medication is to give the right 
medication to the right patient after proper identification. 
Drugs should be dispensed at the right dose, route of 
administration, form and duration of treatment. For 
patients, the prescription container label may be the only 
source of instructions on how to take their medicines. In 
the United States, the legal requirements for a prescription 
label are set by federal law and state statutes. The 
container should be comparable to that which 
manufacturers use to package drug products and should 
preserve a product’s identity, strength, quality, and purity 
and prevent contamination. Safety features such as a child-
resistant closure should be provided. Pharmaceutical 
products purchased from international online pharmacies 
are not approved by the FDA and may not meet US 
guidelines for labeling and packaging. Pharmacy staff 
works in close collaboration with the different medical 
departments, nursing services and dietary department to 
meet customer needs. This is particularly useful with 
complex patients who have multiple prescribers and more 
than one condition requiring treatment. Medication 
dispensing databases are increasingly available for 
pharmacists on large populations, particularly in countries 
that provide universal coverage for medicines [28-30]. 
B. Delivery of transition care medications 
Usually home care prescriptions are dispensed and refilled 
from the ambulatory pharmacy as a service to this patient 
population. Medicare beneficiaries are covered by the US 
Social Security Amendment, passed in 1965 and then 
amended in 1972, which extended health care services to 
all persons 65 years of age or older. Medicare Part A covers 
inpatient hospital care, hospice care, and home health 
care, with deductibles and limits placed on each type of 
care. Beneficiaries are also eligible for Medicare Part B 
coverage, which, for a relatively small health insurance 
premium, allows senior citizens to obtain extended 
coverage for physician services, outpatient hospital 
services, home health care services, and a limited number 
of outpatient drugs (e.g., hepatitis B vaccine, 
immunosuppressant drugs, pneumococcal and influenza 
vaccines, and some oral cancer drugs). Optimizing the TOC 
process, reducing medication errors, and preventing ADEs 
are important focus areas in the current health care 
system, as emphasized by The Joint Commission and other 
health care organizations. Providing a complete and 
accurate medication reconciliation (MR) at the time of 
transition is important and improves TOC, especially since 
most AEs that occur during TOC are adverse drug events. 
Another study determined that nearly 50% of patients 
experienced at least one outpatient medical error caused 
by failure to implement the intended discharge plans for 
recently hospitalized patients. Ambulatory pharmacists 
have the unique opportunity and skillset to develop and 
participate in TOC processes that will enhance medication 
safety and improve patient care [31-34].  
C. Pharmacists-led medication reconciliation 
Medication discrepancies arising at care transitions have 
been reported as prevalent and are linked with adverse 
drug events (ADEs) (e.g. re-hospitalization) [35]. More than 
25% of errors can be attributed to incorrect medication 
histories, demonstrating that this is an error-prone 
process. Gleason and colleagues found that more than 33% 
of patients had at least one medication discrepancy at 
admission, and 85% of these originated from the 
medication history. Obtaining an accurate medication 
history during transitions of care has been shown to reduce 
errors that could lead to patient harm and is the foundation 
of the medication reconciliation process. Reconciliation 
involves building a complete list of a person's medications, 
checking them for accuracy, reconciling and documenting 
any changes. Pharmacy personnel can play a key role in 
medication safety and prevention of discrepancies upon 
hospital admission. Buckley and colleagues discovered that 
greater than 97% of medication histories documented by 
health care providers other than pharmacists were 
associated with at least one medication discrepancy [35-
40]. 
D. Patient counseling and education 
In the counseling process, a multi-cultural competence of 
dispenser is among the key factors affecting his/her 
successful communication with patients for achieving 
optimal use of medications. Patient counseling by 
dispenser is a key competency element in the medication 
treatment process. To this end, it is critical for the 
dispensers to provide desirable and understandable 
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information to patients about their dispensed medications. 
The dispenser is in a critical position to answer whatever 
concerns and enquiries of patients toward their 
medications and even alternate therapeutic approaches 
they may seek or hear from others. Accordingly, the 
Australian Pharmaceutical Advisory Council outlines the 
type of information and resources that should be delivered 
to patients. Moreover, list of medicines provided on exit 
from the healthcare facility should be prepared in 
communication and collaboration with the patient for ease 
of improving adherence to treatment regimens and patient 
outcomes. However, for a non-teaching facility, the 
addition of clinical pharmacy services may alter workflow 
pace because the practitioner may be accustomed to 
moving from one patient to the next without stopping to 
discuss the treatment plan with the health care team. It 
may be more challenging to provide recommendations and 
interventions for each individual patient, and as such, an 
alternative workflow may be necessary. This may include a 
pharmacist-specific patient and family education visit, 
which may reduce the time the practitioner needs to spend 
with each patient, thus allowing a potential increase in 
provider patient volume. Crowd and noisy hospital 
environment, over-loaded physicians, and innumerable 
patients limited hospital staffs to supply more professional 
services. Counseling people were increased 4 folds in 2015 
compared to in 2013. On the one hand, with the 
development of the pharmaceutical counseling center, 
more and more people realized the importance of drug 
safety and accuracy. [41-46]. 
E. HMR 
MMRs are an excellent example of optimal pharmaceutical 
care delivery. MMRs were originally conducted by 
pharmacists and have been a prime component of the 
expanded clinical services provided by pharmacists 
worldwide. Home medication reviews are a subtype of 
MMRs in which patients are interviewed by a health 
professional in their own home. This was originally 
designed for pharmacists to recover relevant information 
from the patient’s home that is of value and could 
otherwise be overlooked by health care professionals. It is 
intended for the pharmacist to observe the patient’s 
management of their medications and to educate the 
patient so that the quality use of medicines can be 
achieved. The HMR has the potential to be a useful tool in 
patients' management of their medications. There are 
clear benefits when per-formed well. HMR is an Australian 
initiative introduced in 2001 to improve quality use of 
medicines. The pharmacist reviews the patient’s drug 
therapies for drug interactions, adverse effects and 
inconsistencies with the current published views on 
therapies. GPs plays a vital role in determining whether 
patients are likely to benefit from this service as HMRs 
require a referral from a GP. Studies show that GPs believe 
HMRs potentially improve medication safety, awareness 
and management. Home medicines review can: 
1. Clarify and assure patients about proper use of their 
medications. 
2. Increase the patients understanding of their 
physicians’ clinical intentions. 
3. Promote co-operation between the patient and his 
clinician. 
4. Promote better patient compliance with medication 
regimens and dosages. 
5. Maximize health outcomes from treatment provided 
[47-51]. 
 
Barriers to Pharmaceutical Care 
A variety of factors have impeded pharmacists’ ability to 
implement pharmaceutical care and can be grouped into four 
general categories. 
 
A. Individual pharmacist characteristics 
Studies have been conducted to establish the challenges to 
Pharmaceutical care implementation in community and 
hospital pharmacies in   developed countries.  The 
pharmacists’ attitudes such as the lack of understanding of 
the concept, misconception such as patients’ unwillingness 
to pay, fear of changing roles and lack of personal 
motivation reported. Pharmacists who commit to 
managing the pharmacotherapy of their patients must be 
familiar with current advances in the treatment of common 
diseases and with literature resources/ databases that are 
available to assist them to make sound therapeutic 
decisions. The attitudes are characterized by conflicts and 
egos resulting from differences in status/authority, 
responsibilities, and training. Finally, oral and written 
communication skills are central to the provision of 
pharmaceutical care. Pharmacists need to be trained in 
applying general affective communicative strategies, 
listening and reflecting, and responding to uttered cues. 
Combined with non-specific verbal behavior techniques, 
such as social talk, these techniques are especially 
important in addressing patient concerns. Pharmacists 
should refine their communication styles and patterns 
constantly to ensure patients receive the information they 
require for effective treatment. They not only create a safe 
and inviting atmosphere between the pharmacist and 
patient but also encourage patients to disclose their 
emotions and concerns. Furthermore, changing the 
consultation dynamic may also help; from a professional 
“coolness” approach at the beginning of the consultation 
to becoming warmer and avoiding non-verbal cut-offs at 
the end. Incorporating more open-ended questions and 
follow-up questions throughout the home visit could 
increase the flexibility of the protocol and might invite 
patients to express their concerns. [46], [52-56]. 
B. Practice-Setting Constraints  
There are numerous constraints involved, consisting of 
supply-side (e.g. workforce shortages), demand-side (e.g. 
obstacles of access to healthcare) and healthcare system 
constraints (e.g. regulatory constraints). Resource 
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constraints and other factors associated with a particular 
practice setting also are mentioned frequently as barriers 
to the provision of pharmaceutical care. For example, 
pharmacists often complain that they do not have time to 
provide pharmaceutical care in addition to their normal 
responsibilities. A lack of financial resources also is 
mentioned often as a barrier to the provision of 
pharmaceutical care. Under constrained financial 
conditions, healthcare services need to demonstrate that 
they remain cost-effective, given the investment in their 
provision. Purchasing additional equipment, hiring and 
training additional personnel, and redesigning the 
pharmacy can be quite expensive. A further complication 
exists when the management of the pharmacy 
organization is not committed to the provision of 
pharmaceutical care. In that situation, support for even 
minor modifications of the practice environment may be 
completely absent. Most pharmacists should be able to 
offer pharmaceutical care to a limited number of patients 
without incurring large expenses. Then, as the number of 
patients receiving care is expanded, pharmacists can 
gradually modify the environment to be more conducive to 
patient-oriented services [19], [57-60]. 
C. Intra-professional Barriers 
A fragmented system can be defined as one lacking the 
integration required to achieve unity of effort. Each part of 
the system tends to focus on internal tasks and resources, 
overlooking the system as a whole. Fostering IPC has 
become one of the core demands of policymakers, funding 
parties, and health care professionals in practice 
worldwide. Patients benefit when pharmacists work 
together. Good team functioning is associated with 
improved patient outcomes, heightened staff satisfaction, 
and reduced burnout. In contrast, poor team functioning is 
associated with poor patient care through adverse events, 
lack of coordination, and spiraling costs. The NAPRA 
highlights the importance of collaboration in pharmacist 
practice. This standard applies not only to pharmacist 
collaboration with other health care professionals but also 
to pharmacist collaboration with other pharmacists. Thus, 
pharmacists from all practice settings and the 
organizations that represent them must work 
cooperatively to develop a common agenda for the 
implementation of pharmaceutical care if this new mission 
is ever to be fully realized by the profession [60-64]. 
D. Compensation Benefits 
Expansion of scope of practice and diminishing revenues 
from dispensing are requiring pharmacists to increasingly 
adopt clinical care services into their practices. Pharmacists 
must be able to receive payment in order for provision of 
clinical care to be sustainable. However, the body of 
evidence supports the feeling that pharmaceutical care 
services add value to patient care by enhancing patient 
compliance, improving patient outcomes, and reducing 
healthcare costs. A Canadian strategy for improving the 
provision of patient-centered care by pharmacists, 
identifies obtaining remuneration for professional services 
as a key area of action to support such activities. The cost 
of the prescription then is based upon the cost to the 
pharmacy plus a handling charge. As the pharmacy practice 
literature reporting the clinical benefits of pharmacist 
cognitive services continues to grow and pharmacy 
revenues from dispensing alone decrease in light of generic 
drug price reductions and other factors, the profession is 
advocating for appropriate payment for clinical services. 
Pharmacists also, with some success, has billed insurance 
companies for pharmaceutical care services that were 
provided to his patients. Indeed, lack of remuneration for 
services has been cited by community pharmacists as a key 
barrier preventing the greater provision of clinical services 
[59], [65-67].  
 
Medication risk management 
Different medication review procedures are internationally 
used in both outpatient and inpatient settings. The accurate 
medication history recording and the medication chart is the 
basis for safe pharmacotherapy and a starting point for 
medication reviews. strategies to prevent ADRs and drug-
related hospital admissions are urgently needed, particularly 
for elderly patients. In addition to other medication safety 
initiatives, national and international organizations 
recommend including pharmacists on health care teams to 
improve medication safety [68,69]. For each DRP, a specific 
recommendation should be addressed to the health care team. 
Each recommendation should be discussed with the healthcare 
team, and the physician decided if he followed the 
recommendations. The medication should be checked again 
and registered, if the recommendation is partly or fully 
followed. 
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Exhibit 1. Potential Drug Therapy Problems [70] 
 Use of drug when no drug is necessary 
 Medical condition which is self-limiting itself 
 An inappropriate therapy for a specific condition 
 Incomplete vaccination 
 Inappropriate dose, dosage regimen, dosage form, dose schedule, route or method of administration 
 Therapeutic duplication 
 Hypersensitivity of patient to component of a drug 
 Adverse drug or devise related events or potential for such event 
 There are clinically significant drug-drug, drug-disease, drug-food or drug-reagent interaction (during diagnosis) 
 Drug or non-drug therapy has been affected by social, recreational or non-traditional drug use by the patients or others 
 Patient is not receiving the full benefit from the prescribed drug or non-drug therapy 
 Drug or non-drug therapy affected by the financial condition of the patient 
 Patient’s lacking in understanding/misconception of the drug/therapy 
 Patient non-adherence to drug/therapy 
 
High prevalence of polypharmacy in older adults has been 
widely reported1. Multiple studies have mentioned that 
polypharmacy increases the risk of adverse drug reactions, 
hospitalization, falls, mortality, and other adverse health 
outcomes in elderly patients. Pharmacogenomics allow 
identify how hereditary profile affects an individual response 
to drugs. As a strategy for optimizing medication usage, 
pharmacogenomics became an important element of 
precision medicine. A recent study has demonstrated that 
precision medicine has significant potential in people with 
polypharmacy particularly in older adults with history of 
urgent care utilization [72]. 
 
 
 
 
Poor medication management during or immediately after 
hospital admission increased the risk of readmission in the 
next month by 28%. Hospital admissions and discharges, 
interdepartmental transfers, or care shared between a 
specialist and a GP, are often dangerous times for patients, 
especially those with long-term conditions or taking multiple 
medicines. Patients may take a number of medicines in 
complex regimens so there is a high potential for drug 
interactions, particularly given the substantial comorbidity and 
mortality rates in this population. There are significant 
discrepancies between the medicines people take at home, 
the medicines GPs think they are taking at home, medicines 
listed in GP referral letters, medicines people obtain from 
pharmacies, the medicines recorded when they are admitted 
to hospital, and when they leave hospital, and the medicines 
detailed in their official discharge summary. 
 
 
  
 
 
 
 
 
 
 
letters from hospital 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
environment  
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Exhibit 2. Drug-Related Problems Encountered by 
Pharmacist Monitoring [72] 
 Untreated condition 
 Improper drug selection 
 Under-dose 
 Failure of patient to receive drug 
 Overdose 
 ADR 
 Drug-food interaction 
 Drug without indication 
 Nonadherence 
 Duplicate therapy 
 Allergies 
 Requiring renal or hepatic adjustments 
 Poly-pharmacy 
 
Pharmaceutical care focuses on activities that lead to positive 
patient outcomes, and accepting end results of medication 
therapy remains important in providing such services. A 
pharmacist must be a scientific problem solver, a good 
communicator, educator and learner. Primary activities 
involved in pharmaceutical care include: obtaining a 
medication history, identifying real and potential DRPs, 
developing a pharmacy care plan to include implementing and 
monitoring parameters to resolve and prevent drug-related 
problems, and evaluating the plan to determine if clinical 
outcomes have been achieved through documentation, 
patient consultation follow-up to determine if the desired 
clinical outcomes have been achieved. Future trends in drug 
development will increase the pharmacist's role in drug 
selection, in an effort to ensure both safety and cost 
containment. All this is achievable through competent skills 
and knowledge gained to provide reliable coordinated 
services.  There was a trend for the number of pharmacist-
hours containing at least one potentially serious dispensing 
error to increase as the prescription-filling rate accelerated. 
Outpatient pharmacies with high volumes should set a limit to 
the number of prescriptions filled by their pharmacists and 
should experiment with quality assurance systems to reduce 
dispensing errors and subsequent legal liabilities [72-74].  
 
Outpatient service through telemedicine 
Telemedicine refers to the delivery of clinical services using 
technology that allows two-way, real time, interactive 
communication (including telemonitoring and video including 
follow-up telephone calls) between the patient and the 
pharmacist at a distant site. In the Unites States, the increasing 
shortage of primary care providers and specialists represents 
an opportunity for pharmacists to assume a more prominent 
role managing patients with chronic disease in the ambulatory 
care setting. However, lack of reimbursement may pose a 
barrier to the provision of care by pharmacists using 
telemedicine [75]. Generally, telemedicine modalities fall into 
one of two categories: synchronous or asynchronous. In 
synchronous telemedicine, a confidential, interactive, two-
way audio and video connection replaces the in-person, face-
to-face visit, using specialized equipment to perform an 
accurate and reliable history and physical exam. Synchronous 
telemedicine models are typically used to manage acute and 
chronic diseases that rely significantly on a real-time patient 
interaction or the physical exam, such as the management of 
chronic infectious diseases, pulmonary medicine, diabetes 
management and telepsychiatry [76]. 
 
Exhibit 3. Terminologies Associated with Telehealth [77-79] 
Term Definition 
Telehealth The term telehealth is used to encompass a broader definition of remote healthcare that does not always 
involve clinical services.  
Telemedicine Telemedicine is the use of medical information exchanged from one site to another via electronic 
communications to improve patients’ health status. Telemedicine is the use of two-way real-time interactive 
audio and video between places of lesser and greater medical capability or expertise to provide and support 
health care, when distance separates participants who are in different geographical locations.  
Telecare Telecare is the term that relates to technology that enables patients to maintain their independence and 
safety while remaining in their own homes. This technology includes mobile monitoring devices, medical alert 
systems, and telecommunications technology like computers and telephones. Continuous remote monitoring 
of patients enables telecare to track lifestyle changes over time as well as receiving alerts relating to real-time 
emergencies.  
Teleconsultation Consultation between a provider and specialist at distance using either store and forward telemedicine or real-
time videoconferencing.  
Tele-mentoring The use of audio, video, and other telecommunications and electronic information processing technologies to 
provide individual guidance or direction.  
Telemonitoring The process of using audio, video, and other telecommunications and electronic information processing 
technologies to monitor the health status of a patient from a distance.  
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Exhibit 3. Terminologies Associated with Telehealth [77-79] 
Term Definition 
Telepharmacy Telepharmacy is defined as the provision of pharmaceutical care to patients through the use of 
telecommunications and information technologies.  
Store-and-Forward 
“Asynchronous 
Communication” 
Type of telehealth encounter or consult that uses still digital images of patient data for rendering a medical 
opinion or diagnosis (e.g. in radiology, pathology, dermatology, ophthalmology, and wound care). Store and 
forward includes the asynchronous transmission of clinical data from one site to another (e.g. email).  
 
In US 20% of the total people are rural based, only 9% of their 
physicians have posting there. It is estimated that as of 2016 
at least 20% of the US population did not have equal access to 
health care. In addition to rural areas, telemedicine services 
have also expanded into prisons, military bases, and school 
systems. Among 110 million medical visits were conducted in 
2015, 59 million were conducted on-line, over the internet, or 
by using mobile devices, accounting more than 50% of patient 
visits. Since pharmacists are not recognized by CMS as 
healthcare providers, they cannot be reimbursed for services 
rendered under most traditional fee-for-service 
arrangements. In conclusion, pharmacists have a unique 
opportunity to use telemedicine models as a means to improve 
access to care and chronic disease management in both rural 
and urban populations within the ambulatory setting. 
Electronic health (eHealth) tools incorporate many 
opportunities for patients to increase their engagement 
through focused disease-specific learning, options to receive 
regular feedback and frequent reinforcement (e.g., peripheral 
monitoring devices). Additional inbuilt support functions that 
assess progress, provide goal setting and problem solving, aim 
to increase the patient’s skill and confidence in managing their 
health problems. Supplementary motivational interviewing 
and cognitive behavioral components can also be provided via 
the internet, mobile device or telephone [80,81]. Micro-
hospitals are 24-hour, small inpatient facilities with an average 
of 2 to 10 beds, designed to provide a diversity of healthcare 
services consistent with community demands. In addition, 
they seek to combine a cost-effective healthcare vehicle with 
potential time-dependent triage/transfer capabilities to a 
nearby large medical center. This smaller cost-effective entity 
represents an ideal vehicle for telemedicine, whereby 
specialists are always on hand for interpretation and 
consultation, with minimal patient waiting [82]. 
 
Challenges of chronic health management 
There are significant differences between acute and chronic 
disease that require different approaches to care. The 
American health care system is built on an acute care 
paradigm; in general, acute care problems have a rapid onset, 
are short in duration, and result from a single cause. Chronic 
care problems are slower to develop, longer in duration, and 
have multiple causes, some of which occur years before the 
onset of symptoms. These differences limit the current 
system's ability to deal effectively with a number of unique 
challenges in managing chronic disease: 
 The social, behavioral, and psychosocial elements 
associated with chronic disease (e.g., the often-
unrecognized elements of self-image related to 
being a person with disease). 
 The need for continuing care, often throughout the 
remainder of the patient's life. 
 The influence of chronic disease on the patient's 
extended family and the very real need for the 
family's ongoing support for long-term success. 
 The influence of lifestyle factors in both the 
causation and long-term management of chronic 
disease. 
 
Caring for the population of patients with chronic conditions 
requires a new paradigm—one that encompasses longitudinal 
care and unplanned episodes of care. To a large extent, the 
development and implementation of such a system will hinge 
on addressing 4 specific challenges17: 
 
 Realigned Reimbursement—In general, payment for 
health care services is triggered by acute care 
episodes. There must be a mechanism whereby 
providers are compensated to manage a broad range 
of chronic conditions that never resolve and that are 
not characterized by episodes of care. 
 Team-Based Care—An adequate number of 
nonphysician health care team members in 
disciplines such as nursing, social work, community 
health coaching, and pharmacy must be trained and 
available to coordinate proven team-based care. 
 Patient and Family Engagement—Expanded 
opportunities for patient and family engagement in 
self-management programs are essential for 
improving patients' ability to manage their conditions 
and adhere to treatment plans. 
 Information Sharing—The current acute episode-
focused medical record system must be redesigned to 
improve clinicians' ability to share information 
regarding patients with chronic disease and facilitate 
the use of evidence-based decision support in their 
care [83]. 
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Epilogue 
In most countries, existing health care systems do not optimize 
the practices of all health professionals and cost an increasing 
amount without comparable increases in quality and 
accessibility. Numerous proposals have been made on how to 
address these shortcomings. Achieving these goals require 
different health professionals to work in collaboration with 
each other to meet the health needs of patients. In order for 
that to happen, governments must work with all key 
professional groups to use all available resources of the system 
most effectively and, importantly, pharmacists must be 
recognized as the professional that coordinates drug therapy 
management. In addition, governments must put in place 
policies and a regulatory and funding environment that 
facilitates team-based care and acknowledges and supports 
the professional competencies of all health professions.  
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